MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial

Sepideh Saadatmand, H. Amarens Geuzinge, Emiel J. T. Rutgers, Ritse M. Mann, Diderick B. W. de Roy van Zuidewijn, Harmien M. Zonderland, Rob A. E. M. Tollenaar, Marc B. Lobbes, Margreet G. E. M. Ausems, Martijne van t'Riet, Maartje J. Hooning, Ingeborg Mares-Engelberts, Ernest J. T. Luiten, Eveline A. M. Heijnsdijk, Cees Verhoef, Nico Karssemeijer, Jan C. Oosterwijk, Inge-Marie Obdeijn, Harry J. de Koning, Madeleine M. A. Tilanus-Linthorst*FaMRIsc Study Grp, Kristien Keymeulen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1136-1147
Number of pages12
JournalLancet oncology
Volume20
Issue number8
DOIs
Publication statusPublished - Aug 2019

Keywords

  • CARCINOMA IN-SITU
  • POPULATION
  • DENSITY
  • COHORT

Cite this

Saadatmand, S., Geuzinge, H. A., Rutgers, E. J. T., Mann, R. M., van Zuidewijn, D. B. W. D. R., Zonderland, H. M., Tollenaar, R. A. E. M., Lobbes, M. B., Ausems, M. G. E. M., van t'Riet, M., Hooning, M. J., Mares-Engelberts, I., Luiten, E. J. T., Heijnsdijk, E. A. M., Verhoef, C., Karssemeijer, N., Oosterwijk, J. C., Obdeijn, I-M., de Koning, H. J., ... Keymeulen, K. (2019). MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial. Lancet oncology, 20(8), 1136-1147. https://doi.org/10.1016/S1470-2045(19)30275-X